New nurse-led protocols for stroke patients, based on ACU research, led by the Nursing Research Institute, have resulted in changes to policy, guidelines and clinical practice in Europe and Australia. The protocols were developed through the Quality in Acute Stroke Care (QASC) Trial (published in the Lancet, 2011) to manage fever, hyperglycaemia and swallowing (FeSS) post-stroke.
Professor Sandy Middleton FACN, FAAN is a Professor of Nursing and Director of the Nursing Research Institute at St Vincent’s Health Network Sydney, St Vincent’s Hospital Melbourne and Australian Catholic University. She focusses on stroke and the way research can improve care, particularly analysing the way nurses can initiate care to improve patient recovery.
Professor Middleton was the lead investigator on the landmark NHMRC-funded QASC cluster trial that demonstrated decreased death and dependency following implementation of nurse-initiated protocols to manage fever, hyperglycaemia and swallowing post-stroke, winning multiple national and international awards including ACU’s Vice-Chancellor’s Staff Excellence Award, Excellence in Research and Research Partnerships in 2019. These protocols have been translated into 64 hospitals in 17 European countries and in adopted in 36 NSW hospitals. She has published in high impact journals including The Lancet and The New England Journal of Medicine.
Australian Health Journal spoke with Professor Sandy Middleton on these significant achievements in nurse-led acute stroke care.
-
Inaugural Rural and Remote Health Awards
Rural communities are a foundation of the economy and society and must be kept healthy.
There are significant personal, professional and financial rewards for rural healthcare professionals. However, there are also challenges – isolation, long hours, confusion about where to turn for support.
To acknowledge and celebrate the work of Rural and Remote Health Professionals, Rural Health Pro have launched the inaugural National Rural and Remote Health Awards.
-
Recognising service in health regulation
In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.
-
Future of minimally invasive surgery
Macquarie University Hospital is the first hospital in Australia to have three robotic surgical systems. It remains the busiest centre for robotic urology in New South Wales and has rapidly growing programs in other areas. What is behind the Hospital’s success?
Conjoint Associate Professor Walter Kmet, CEO of Macquarie University Hospital, says that the story of robotics at the Hospital is driven by its academic health sciences identity.
